Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

ClinicalTrials.gov ID: NCT04200248

Public ClinicalTrials.gov record NCT04200248. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 3:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double Masked and Active Controlled Phase II Study Assessing the Efficacy and Safety of Intravitreal Injections of RBM-007 Monotherapy and RBM-007 in Combination With Eylea® Compared to Eylea® Monotherapy

Study identification

NCT ID
NCT04200248
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ribomic USA Inc
Industry
Enrollment
94 participants

Conditions and interventions

Interventions

  • RBM-007 Injectable Solution Drug
  • Aflibercept Drug
  • Sham Drug

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2019
Primary completion
Nov 18, 2021
Completion
Dec 21, 2021
Last update posted
Jun 7, 2023

2019 – 2021

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85053
Retinal Consultants Medical Group Sacramento California 95841
Bay Area Retina Associates Walnut Creek California 94704
Advanced Research, LLC Coral Springs Florida 33067
Georgia Retina, P.C. Marietta Georgia 30060
Raj K. Maturi, M.D., P.C. Indianapolis Indiana 46290
Valley Retina Institute, PA McAllen Texas 78503
Medical Center Ophthalmology Associates San Antonio Texas 78240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04200248, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04200248 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →